Yanyun Xie
Overview
Explore the profile of Yanyun Xie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
388
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang H, Han Y, Zhang Y, Zeng J, He X, Cheng J, et al.
Adv Sci (Weinh)
. 2025 Jan;
e2408753.
PMID: 39836535
Renal fibrosis is a common pathway involved in the progression of various chronic kidney diseases to end-stage renal disease. Recent studies show that mitochondrial injury of renal tubular epithelial cells...
2.
Sun J, Cheng K, Xie Y
Biomolecules
. 2025 Jan;
14(12.
PMID: 39766247
Urinary tract infection (UTI) is the most prevalent kind of pathogenic bacteria infection, and the midstream urine culture is regarded as the gold standard in UTI diagnosis. Recently, even with...
3.
Gu L, He X, Zhang Y, Li S, Tang J, Ma R, et al.
Biomed Pharmacother
. 2023 May;
164:114844.
PMID: 37224750
Aims: Acute liver failure (ALF) is a life-threatening disease characterized by abrupt and extensive hepatic necrosis and apoptosis, resulting in high mortality. The approved drug, N-acetylcysteine (NAC), is only effective...
4.
Li S, Zhang Y, Lu R, Lv X, Lei Q, Tang D, et al.
Kidney Int
. 2023 May;
104(2):305-323.
PMID: 37164261
Damage-associated molecular patterns (DAMPs) are a cause of acute kidney injury (AKI). Our knowledge of these DAMPs remains incomplete. Here, we report serum peroxiredoxin 1 (Prdx1) as a novel DAMP...
5.
Li J, Jiang Y, Dai Q, Yu Y, Lv X, Zhang Y, et al.
Front Pharmacol
. 2023 Apr;
14:1188615.
PMID: 37089951
[This corrects the article DOI: 10.3389/fphar.2022.1043945.].
6.
Zhou H, Liu L, Zhao Q, Jin X, Peng Z, Wang W, et al.
Front Immunol
. 2023 Apr;
14:1140755.
PMID: 37077912
Background: Sepsis-associated acute kidney injury (S-AKI) is considered to be associated with high morbidity and mortality, a commonly accepted model to predict mortality is urged consequently. This study used a...
7.
Zhang W, Liu L, Xiao X, Zhou H, Peng Z, Wang W, et al.
Front Immunol
. 2023 Apr;
14:961642.
PMID: 37026010
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the main cause of COVID-19, causing hundreds of millions of confirmed cases and more than 18.2 million deaths worldwide. Acute kidney injury...
8.
Li J, Jiang Y, Dai Q, Yu Y, Lv X, Zhang Y, et al.
Front Pharmacol
. 2022 Dec;
13:1043945.
PMID: 36506525
Renal ischemia-reperfusion injury (IRI) is one of the most common causes of acute kidney injury (AKI). It poses a significant threat to public health, and effective therapeutic drugs are lacking....
9.
Li J, Li X, Huang H, Tao L, Zhang C, Xie Y, et al.
J Oncol
. 2022 Nov;
2022:9359879.
PMID: 36385955
The sarcoendoplasmic reticulum calcium adenosine triphosphatase (ATPase) 3 (), a member of the SERCA protein family, is located at the endoplasmic reticulum. Its main function is to pump Ca2+ into...
10.
Liao X, Lv X, Zhang Y, Han Y, Li J, Zeng J, et al.
Oxid Med Cell Longev
. 2022 Mar;
2022:2453617.
PMID: 35355864
Objective: Mitochondrial damage contributes to extracellular matrix (ECM) deposition and renal fibrosis. In this study, we aimed (1) to investigate whether fluorofenidone (AKF-PD) can attenuate mitochondrial damage in two renal...